Current Portfolio


Using active-graph machine learning (ML) combined with single-cell analysis and deep clinical insights to advance therapeutic candidates for diseases with no or few good medicines.


Unlocking the potential of microfluidics and machine learning to discover modulators of biomolecular condensates in human disease.


Rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency.

Brendan Frey, Ph.D.

Using AI to rapidly accelerate drug discovery and development for rare genetic and chronic diseases.

Bob Nelsen, Rahul Singhvi, Sc.D., and Pat Yang, Ph.D.

Changing the way complex medicines are made and distributed by leveraging technology innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.

Abner Mason

Closing gaps in care and improving lives for diverse patient populations through technology-based patient engagement solutions.


Developing novel technology for cell-specific delivery of CRISPR-Cas9 payloads, a major challenge for gene editing today.

Julio Aguirre-Ghiso, Ph.D., Ari Nowacek, M.D., Ph.D., and Alan Rigby, Ph.D.

Developing first-in-class drugs that target dormant disseminated tumor cells to help prevent the recurrence of cancer.

Tillman Gerngross, Ph.D., and Leonard Zon, M.D.

Using state of the art antibody discovery and optimization strategies, selectively inhibits extracellular enzymes that, when overactive, can cause broad inflammatory response.

Amanda French

Safeguarding birth control through robust technology that addresses the pain points and obstacles of effective birth control.

Matthew Stoudt, Josh Sackman, and David Sackman

Pioneering evidence-based, immersive VRx—a new category of prescription digital therapeutics—including its product EaseVRx, the first virtual reality-based treatment for pain to receive FDA approval as a Class II medical device.

“It has been an honor to work alongside the Magnetic Ventures team. The incredible expertise they bring to the table and their willingness to dig in and share not just their knowledge but also their networks, has been the kind of experience you dream of as a Founder. Their passion and support of our mission has challenged us as a company to think bigger and build better solutions for both our clients and the communities we serve.”

Abner Mason

Founder & CEO, SameSky Health